New stroke drug could help patients treated up to 24 hours after symptoms start
NCT ID NCT07324837
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This Phase 3 trial tests a drug called Fortelyzin® (non-immunogenic staphylokinase) in 990 adults with acute ischemic stroke who can be treated between 4.5 and 24 hours after symptoms begin. Participants receive a single injection of the drug or a placebo. The goal is to see if the drug improves functional outcomes, such as being able to live independently, 90 days later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fortelyzin® (non-immunogenic staphylokinase)
What this could lead to
If successful, this could provide a new treatment option for stroke patients who cannot receive standard therapy within the first few hours, potentially reducing disability.
What could go wrong
This is an early-stage Phase 3 trial, so results may not confirm benefit. There is also a risk of bleeding, as with any clot-busting drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE, ACUTE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Altai Regional Clinical Hospital
NOT_YET_RECRUITINGBarnaul, 656024, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Chelyabinsk Regional Clinical Hospital No. 3
NOT_YET_RECRUITINGChelyabinsk, Russia
Contact Email: •••••@•••••
Contact
-
City Clinical Hospital of Emergency Medical Care No. 25
NOT_YET_RECRUITINGVolgograd, 400138, Russia
Contact Email: •••••@•••••
Contact
-
Interregional Clinical and Diagnostic Center
NOT_YET_RECRUITINGKazan', 420101, Russia
Contact Email: •••••@•••••
Contact
-
Irkutsk Regional Clinical Hospital
NOT_YET_RECRUITINGIrkutsk, 664079, Russia
Contact Email: •••••@•••••
Contact
-
Kaluga Regional Clinical Hospital
NOT_YET_RECRUITINGKaluga, 248007, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Leningradskaya Regional Clinical Hospital
NOT_YET_RECRUITINGSaint Petersburg, 194291, Russia
Contact Email: •••••@•••••
Contact
-
N.I. Pirogov Russian National Research Medical University
NOT_YET_RECRUITINGMoscow, 117997, Russia
Contact Email: •••••@•••••
Contact
-
Ryazan Regional Clinical Hospital
NOT_YET_RECRUITINGRyazan, Ryazan Oblast, 390039, Russia
Contact Email: •••••@•••••
Contact
-
S.V. Ochapovsky Research Institute - Regional Clinical Hospital No. 1
NOT_YET_RECRUITINGKrasnodar, 350086, Russia
Contact Email: •••••@•••••
Contact
-
Sergiev Posad District Hospital
NOT_YET_RECRUITINGSergiyev Posad, 141301, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sverdlovsk Regional Clinical Hospital No. 1
NOT_YET_RECRUITINGYekaterinburg, 620102, Russia
Contact Email: •••••@•••••
Contact
-
Tver Regional Clinical Hospital
NOT_YET_RECRUITINGTver', 170036, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Ulyanovsk Regional Clinical Hospital
NOT_YET_RECRUITINGUlyanovsk, Russia
Contact Email: •••••@•••••
Contact
-
V.I. Voynov Orenburg Regional Clinical Hospital
RECRUITINGOrenburg, Russia
Contact Email: •••••@•••••
Contact